Organization
Pharmacosmos
2 clinical trials
Clinical trial
A Phase III, Prospective, Open-label, Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia Due to NDD-CKD or With Iron Deficiency Anemia Who Are Intolerant or Unresponsive to Oral IronStatus: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
An Open-label, Dose-escalation, Dose-finding, and Proof-of-concept Trial of SP-420 in Subjects With Transfusion-dependent β-thalassemiaStatus: Recruiting, Estimated PCD: 2024-07-01